220 related articles for article (PubMed ID: 29859535)
1. Toll-like receptor 2 activation primes and upregulates osteoclastogenesis via lox-1.
Ohgi K; Kajiya H; Goto-T K; Okamoto F; Yoshinaga Y; Okabe K; Sakagami R
Lipids Health Dis; 2018 Jun; 17(1):132. PubMed ID: 29859535
[TBL] [Abstract][Full Text] [Related]
2. Arsenic augments the uptake of oxidized LDL by upregulating the expression of lectin-like oxidized LDL receptor in mouse aortic endothelial cells.
Hossain E; Ota A; Karnan S; Damdindorj L; Takahashi M; Konishi Y; Konishi H; Hosokawa Y
Toxicol Appl Pharmacol; 2013 Dec; 273(3):651-8. PubMed ID: 24145059
[TBL] [Abstract][Full Text] [Related]
3. Palmitic acid enhances lectin-like oxidized LDL receptor (LOX-1) expression and promotes uptake of oxidized LDL in macrophage cells.
Ishiyama J; Taguchi R; Yamamoto A; Murakami K
Atherosclerosis; 2010 Mar; 209(1):118-24. PubMed ID: 19782984
[TBL] [Abstract][Full Text] [Related]
4. Varenicline enhances oxidized LDL uptake by increasing expression of LOX-1 and CD36 scavenger receptors through α
Kanaoka Y; Koga M; Sugiyama K; Ohishi K; Kataoka Y; Yamauchi A
Toxicology; 2017 Apr; 380():62-71. PubMed ID: 28202387
[TBL] [Abstract][Full Text] [Related]
5. Lectin-like oxidized low-density lipoprotein receptor-1 abrogation causes resistance to inflammatory bone destruction in mice, despite promoting osteoclastogenesis in the steady state.
Nakayachi M; Ito J; Hayashida C; Ohyama Y; Kakino A; Okayasu M; Sato T; Ogasawara T; Kaneda T; Suda N; Sawamura T; Hakeda Y
Bone; 2015 Jun; 75():170-82. PubMed ID: 25744064
[TBL] [Abstract][Full Text] [Related]
6. LOX-1 is involved in TLR2 induced RANKL regulation in peri-implantitis.
Zhang Q; Liu J; Ma L; Bai N; Xu H
Int Immunopharmacol; 2019 Dec; 77():105956. PubMed ID: 31655342
[TBL] [Abstract][Full Text] [Related]
7. Lipopolysaccharide induced LOX-1 expression via TLR4/MyD88/ROS activated p38MAPK-NF-κB pathway.
Zhao W; Ma G; Chen X
Vascul Pharmacol; 2014 Dec; 63(3):162-72. PubMed ID: 25135647
[TBL] [Abstract][Full Text] [Related]
8. Involvement of toll-like receptor 2 and 4 in association between dyslipidemia and osteoclast differentiation in apolipoprotein E deficient rat periodontium.
Tomofuji T; Ekuni D; Azuma T; Irie K; Endo Y; Kasuyama K; Yoneda T; Morita M
Lipids Health Dis; 2013 Jan; 12():1. PubMed ID: 23295061
[TBL] [Abstract][Full Text] [Related]
9. Neogambogic Acid Suppresses Receptor Activator of Nuclear Factor κB Ligand (RANKL)-Induced Osteoclastogenesis by Inhibiting the JNK and NF-κB Pathways in Mouse Bone Marrow-Derived Monocyte/Macrophages.
Jin G; Wang FF; Li T; Jia DD; Shen Y; Xu HC
Med Sci Monit; 2018 Apr; 24():2569-2577. PubMed ID: 29698379
[TBL] [Abstract][Full Text] [Related]
10. FTY720 inhibited proinflammatory cytokine release and osteoclastogenesis induced by Aggregatibacter actinomycetemcomitans.
Yu H; Herbert BA; Valerio M; Yarborough L; Hsu LC; Argraves KM
Lipids Health Dis; 2015 Jul; 14():66. PubMed ID: 26138336
[TBL] [Abstract][Full Text] [Related]
11. Dual effect of WIN-34B on osteogenesis and osteoclastogenesis in cytokine-induced mesenchymal stem cells and bone marrow cells.
Seo BK; Ryu HK; Park YC; Huh JE; Baek YH
J Ethnopharmacol; 2016 Dec; 193():227-236. PubMed ID: 27401292
[TBL] [Abstract][Full Text] [Related]
12. Caffeic acid 3,4-dihydroxy-phenethyl ester suppresses receptor activator of NF-κB ligand–induced osteoclastogenesis and prevents ovariectomy-induced bone loss through inhibition of mitogen-activated protein kinase/activator protein 1 and Ca2+–nuclear factor of activated T-cells cytoplasmic 1 signaling pathways.
Wu X; Li Z; Yang Z; Zheng C; Jing J; Chen Y; Ye X; Lian X; Qiu W; Yang F; Tang J; Xiao J; Liu M; Luo J
J Bone Miner Res; 2012 Jun; 27(6):1298-1308. PubMed ID: 22337253
[TBL] [Abstract][Full Text] [Related]
13. MyD88 but not TRIF is essential for osteoclastogenesis induced by lipopolysaccharide, diacyl lipopeptide, and IL-1alpha.
Sato N; Takahashi N; Suda K; Nakamura M; Yamaki M; Ninomiya T; Kobayashi Y; Takada H; Shibata K; Yamamoto M; Takeda K; Akira S; Noguchi T; Udagawa N
J Exp Med; 2004 Sep; 200(5):601-11. PubMed ID: 15353553
[TBL] [Abstract][Full Text] [Related]
14. DOK3 Modulates Bone Remodeling by Negatively Regulating Osteoclastogenesis and Positively Regulating Osteoblastogenesis.
Cai X; Xing J; Long CL; Peng Q; Humphrey MB
J Bone Miner Res; 2017 Nov; 32(11):2207-2218. PubMed ID: 28650106
[TBL] [Abstract][Full Text] [Related]
15. Chronic Exposure of Gingival Fibroblasts to TLR2 or TLR4 Agonist Inhibits Osteoclastogenesis but Does Not Affect Osteogenesis.
Karlis GD; Schöningh E; Jansen IDC; Schoenmaker T; Hogervorst JMA; van Veen HA; Moonen CGJ; Łagosz-Ćwik KB; Forouzanfar T; de Vries TJ
Front Immunol; 2020; 11():1693. PubMed ID: 32793243
[TBL] [Abstract][Full Text] [Related]
16. A Modified Glycosaminoglycan, GM-0111, Inhibits Molecular Signaling Involved in Periodontitis.
Savage JR; Pulsipher A; Rao NV; Kennedy TP; Prestwich GD; Ryan ME; Lee WY
PLoS One; 2016; 11(6):e0157310. PubMed ID: 27308827
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of receptor activator of nuclear factor-κB ligand- or lipopolysaccharide-induced osteoclast formation by conophylline through downregulation of CREB.
Koide N; Kondo Y; Odkhuu E; Ulziisaikhan J; Ukaji T; Yokochi T; Umezawa K
Immunol Lett; 2014 Sep; 161(1):31-7. PubMed ID: 24792671
[TBL] [Abstract][Full Text] [Related]
18. Peptidoglycan and lipopolysaccharide synergistically enhance bone resorption and osteoclastogenesis.
Kishimoto T; Kaneko T; Ukai T; Yokoyama M; Ayon Haro R; Yoshinaga Y; Yoshimura A; Hara Y
J Periodontal Res; 2012 Aug; 47(4):446-54. PubMed ID: 22283724
[TBL] [Abstract][Full Text] [Related]
19. Prostaglandin E(2) is a main mediator in receptor activator of nuclear factor-kappaB ligand-dependent osteoclastogenesis induced by Porphyromonas gingivalis, Treponema denticola, and Treponema socranskii.
Choi BK; Moon SY; Cha JH; Kim KW; Yoo YJ
J Periodontol; 2005 May; 76(5):813-20. PubMed ID: 15898943
[TBL] [Abstract][Full Text] [Related]
20. Ginkgo biloba extract inhibits oxidized low-density lipoprotein (oxLDL)-induced matrix metalloproteinase activation by the modulation of the lectin-like oxLDL receptor 1-regulated signaling pathway in human umbilical vein endothelial cells.
Tsai KL; Chang YL; Huang PH; Cheng YH; Liu DH; Chen HY; Kao CL
J Vasc Surg; 2016 Jan; 63(1):204-15.e1. PubMed ID: 25080882
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
